MORRISVILLE — Clinical research organization Clinipace continues to raise cash as it looks for talent and expands.
The Morrisville-based CRO has raised an additional $10.56 million in debt, according to a securities filing.
That brings its total raised to $14.7 million in a mix of as part of this round opened last October.
Clinipace raised nearly $8 million in equity earlier this year, according to two filings.
Those raises followed a near $6 million funder in 2018 and $10 million in December of 2017.
Founded in 2003, Clinipace Clinical Research was originally built as a software company that has since grown into a global, full-service contract research organization.
Clinipace has more than 600 employees and is looking to fill more than 58 jobs, according to its LinkedIn website.
“[O]ur approach to clinical research is personal. We deliver a level of collaboration and flexibility not possible in a traditional CRO environment,” the company says.
“Our personalized services and solutions, local regulatory expertise and therapeutic leadership are designed to face the most difficult industry challenges across all major therapeutic areas including oncology, gastroenterology, nephrology and urology. We strive to improve the way clinical research is performed and impact the future of health care using the most advanced technology and a CHALLENGE ACCEPTED approach.”
The company aims to bring new therapies and medications to market, impact the lives of patients around the world and provide up-and-coming levels of partnership and efficiency not seen in traditional clinical research organizations.
Providing services in clinical development, regulatory affairs and clinical analysis, the organization’s geographic coverage includes North America, Latin America, Asia-Pacific and Eastern and Western Europe.
Clinipace CEO Jason Montelone joined the team in 2017 after co-founder Jeff Williams resigned as CEO. Montelone has more than 20 years of health care and life science industry experience.
